A detailed history of Bank Of America Corp transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 2,450,838 shares of IOVA stock, worth $19.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,450,838
Previous 2,167,225 13.09%
Holding current value
$19.9 Million
Previous $17.4 Million 32.4%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.28 - $11.9 $2.06 Million - $3.37 Million
283,613 Added 13.09%
2,450,838 $23 Million
Q2 2024

Aug 14, 2024

BUY
$7.78 - $14.19 $4.94 Million - $9.01 Million
634,921 Added 41.44%
2,167,225 $17.4 Million
Q1 2024

May 15, 2024

BUY
$7.59 - $17.47 $4.52 Million - $10.4 Million
595,417 Added 63.55%
1,532,304 $22.7 Million
Q4 2023

Feb 14, 2024

SELL
$3.3 - $8.89 $1.18 Million - $3.18 Million
-357,454 Reduced 27.62%
936,887 $7.62 Million
Q2 2023

Aug 14, 2023

SELL
$5.36 - $9.06 $741,984 - $1.25 Million
-138,430 Reduced 9.66%
1,294,341 $9.11 Million
Q1 2023

May 12, 2023

BUY
$5.53 - $8.22 $1.39 Million - $2.07 Million
252,239 Added 21.37%
1,432,771 $8.75 Million
Q4 2022

Feb 10, 2023

BUY
$5.62 - $10.0 $3.45 Million - $6.13 Million
613,316 Added 108.13%
1,180,532 $7.54 Million
Q3 2022

Nov 14, 2022

BUY
$9.53 - $13.11 $2.41 Million - $3.31 Million
252,570 Added 80.27%
567,216 $5.43 Million
Q2 2022

Aug 12, 2022

SELL
$6.38 - $18.33 $4.52 Million - $13 Million
-708,560 Reduced 69.25%
314,646 $3.47 Million
Q1 2022

May 16, 2022

BUY
$12.38 - $19.1 $2.88 Million - $4.44 Million
232,322 Added 29.37%
1,023,206 $17 Million
Q4 2021

Feb 08, 2022

BUY
$16.55 - $27.63 $3.89 Million - $6.49 Million
234,814 Added 42.23%
790,884 $15.1 Million
Q3 2021

Nov 15, 2021

BUY
$20.35 - $26.63 $1.94 Million - $2.54 Million
95,480 Added 20.73%
556,070 $13.7 Million
Q2 2021

Sep 13, 2021

BUY
$16.33 - $33.07 $7.52 Million - $15.2 Million
460,590 New
460,590 $12 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.